Sign Out
Patients who have known hypersensitivity to Sporanox or its excipients.
Sporanox should only be given to pregnant women in life-threatening cases and when in these cases, the potential benefit outweighs the potential harm to the foetus. Adequate contraceptive precautions should be taken by women of childbearing potential using Sporanox until the next menstrual period following the end of Sporanox therapy.
Terfenadine, astemizole, mizolastine, cisapride, difetilide, quinidine, pimozide, CYP3A4 metabolised HMG-CoA reductase inhibitors eg, simvastatin and lovastatin, triazolam and oral midazolam are cotraindicated with Sporanox capsules.
Continue with Google